Cargando…
Combined Expression of HGFR with Her2/neu, EGFR, IGF1R, Mucin-1 and Integrin α2β1 Is Associated with Aggressive Epithelial Ovarian Cancer
Hepatocyte growth factor receptor (HGFR), also known as c-mesenchymal–epithelial transition factor (c-MET), plays a crucial role in the carcinogenesis of epithelial ovarian cancer (EOC). In contrast, the mechanisms contributing to aberrant expression of HGFR in EOC are not fully understood. In the p...
Autores principales: | Czogalla, Bastian, Dötzer, Katharina, Sigrüner, Nicole, von Koch, Franz Edler, Brambs, Christine E., Anthuber, Sabine, Frangini, Sergio, Burges, Alexander, Werner, Jens, Mahner, Sven, Mayer, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687566/ https://www.ncbi.nlm.nih.gov/pubmed/36359213 http://dx.doi.org/10.3390/biomedicines10112694 |
Ejemplares similares
-
Integrin α2β1 Represents a Prognostic and Predictive Biomarker in Primary Ovarian Cancer
por: Dötzer, Katharina, et al.
Publicado: (2021) -
Immune Heterogeneity Between Primary Tumors and Corresponding Metastatic Lesions and Response to Platinum Therapy in Primary Ovarian Cancer
por: Dötzer, Katharina, et al.
Publicado: (2019) -
Cancer Vaccines Co-Targeting HER2/Neu and IGF1R
por: De Giovanni, Carla, et al.
Publicado: (2019) -
Interpatient Heterogeneity in Drug Response and Protein Biomarker Expression of Recurrent Ovarian Cancer
por: Hoffmann, Oliver Ingo, et al.
Publicado: (2022) -
Protocol to optimize the biobanking of ovarian cancer organoids by accommodating patient-specific differences in stemness potential
por: Trillsch, Fabian, et al.
Publicado: (2023)